17 oct. 2014 - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Ajouté au bande de temps:
Date:
17 oct. 2014
Maintenaint
~ Il y a 11 ans